LIGAND PHARMACEUTICALS INC Annual Return On Equity in % from 2013 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Ligand Pharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2013 to 2023.
  • Ligand Pharmaceuticals Inc Return On Equity for the quarter ending September 30, 2024 was 5.79 %, a 126% increase year-over-year.
  • Ligand Pharmaceuticals Inc annual Return On Equity for 2023 was 7.78 %.
  • Ligand Pharmaceuticals Inc annual Return On Equity for 2022 was -4.43 %, a 161% decline from 2021.
  • Ligand Pharmaceuticals Inc annual Return On Equity for 2021 was 7.22 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 7.78 +12.2 Jan 1, 2023 Dec 31, 2023
2022 -4.43 -11.7 -161% Jan 1, 2022 Dec 31, 2022
2021 7.22 +7.65 Jan 1, 2021 Dec 31, 2021
2020 -0.43 -67.8 -101% Jan 1, 2020 Dec 31, 2020
2019 67.3 +43 +177% Jan 1, 2019 Dec 31, 2019
2018 24.3 +21.1 +654% Jan 1, 2018 Dec 31, 2018
2017 3.22 +3.7 Jan 1, 2017 Dec 31, 2017
2016 -0.48 -152 -100% Jan 1, 2016 Dec 31, 2016
2015 151 +127 +528% Jan 1, 2015 Dec 31, 2015
2014 24.1 -3.74 -13.5% Jan 1, 2014 Dec 31, 2014
2013 27.8 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.